Renaissance Capital logo

DSGN News

US IPO Weekly Recap: Healthcare shines in a 17 IPO week

DRS

In a turbulent week for the IPO market, 17 IPOs and 20 SPACs went public, and one company postponed, defense contractor Leonardo DRS (DRS). While returns cooled off, with just over half of the week’s IPOs finishing below issue, there...read more

Preclinical genetic disease biotech Design Therapeutics prices IPO at $20 high end

Design Therapeutics logo

Design Therapeutics, a preclinical biotech developing small molecule therapies for genetic diseases, raised $240 million by offering 12 million shares at $20, the high end of the range of $18 to $20. Design Therapeutics is developing novel small-molecule...read more

Preclinical genetic disease biotech Design Therapeutics sets terms for $228 million IPO

Design Therapeutics logo

Design Therapeutics, a preclinical biotech developing small molecule therapies for genetic diseases, announced terms for its IPO on Monday. The Carlsbad, CA-based company plans to raise $228 million by offering 12 million shares at a price range of $18 to...read more

US IPO Week Ahead: Cleaning products, crafting machines, and more in a diverse 15 IPO week

DSEY

Updated Monday, 3/22. 15 IPOs are currently scheduled to raise $5.7 billion in the week ahead as IPO activity continues to pick up. The diverse group spans six sectors and includes cleaning products, defense technology, low-cost TVs, crafting...read more